Peptide Hormone News and Research

RSS
Study provides new insight into complex interchange that can raise blood levels of fat in type 1 diabetes

Study provides new insight into complex interchange that can raise blood levels of fat in type 1 diabetes

New book provides authoritative overview of neuroendocrine tumors

New book provides authoritative overview of neuroendocrine tumors

Rhythm, Actavis announce initiation of relamorelin Phase 2b trial for treatment of diabetic gastroparesis

Rhythm, Actavis announce initiation of relamorelin Phase 2b trial for treatment of diabetic gastroparesis

University of Alberta researcher named winner of A.S.P.E.N.'s 2015 Harry M. Vars Award

University of Alberta researcher named winner of A.S.P.E.N.'s 2015 Harry M. Vars Award

University of Alberta's David Lim named recipient of Research Trainee Award by A.S.P.E.N.

University of Alberta's David Lim named recipient of Research Trainee Award by A.S.P.E.N.

Adropin hormone offers a promising treatment option for type 2 diabetes

Adropin hormone offers a promising treatment option for type 2 diabetes

Scientists find that blocking hormone reduces stress-induced infertility in female rats

Scientists find that blocking hormone reduces stress-induced infertility in female rats

New approach promises better drugs for diabetes and osteoporosis

New approach promises better drugs for diabetes and osteoporosis

Georgia Regents Medical Center explores new treatment for Parkinson's disease-related constipation

Georgia Regents Medical Center explores new treatment for Parkinson's disease-related constipation

Retrophin to acquire privately-held company, Kyalin Biosciences

Retrophin to acquire privately-held company, Kyalin Biosciences

Retrophin signs agreement with Novartis for exclusive U.S. license for Syntocinon Nasal Spray

Retrophin signs agreement with Novartis for exclusive U.S. license for Syntocinon Nasal Spray

NGM, MedImmune partner to develop novel therapeutics for treatment of diabetes and obesity

NGM, MedImmune partner to develop novel therapeutics for treatment of diabetes and obesity

Newer class of diabetes medications may also improve cardiovascular health, researchers report

Newer class of diabetes medications may also improve cardiovascular health, researchers report

Aileron Therapeutics concludes first-in-human study of ALRN-5281 Stapled Peptide drug

Aileron Therapeutics concludes first-in-human study of ALRN-5281 Stapled Peptide drug

Rhythm starts RM-131 Phase 2 clinical trial for treatment of chronic constipation

Rhythm starts RM-131 Phase 2 clinical trial for treatment of chronic constipation

SanMedica’s SeroVital-hgh could revolutionize both anti-aging and weight-loss industries

SanMedica’s SeroVital-hgh could revolutionize both anti-aging and weight-loss industries

NOXXON commences NOX-H94 Phase IIa trial to treat anemia of chronic disease

NOXXON commences NOX-H94 Phase IIa trial to treat anemia of chronic disease

Combination of hormones may effectively treat obesity with few side effects

Combination of hormones may effectively treat obesity with few side effects

Exendin-4 could effectively treat addiction

Exendin-4 could effectively treat addiction

Scientists identify mechanisms by which GLP-1 protects against kidney disease, diabetes

Scientists identify mechanisms by which GLP-1 protects against kidney disease, diabetes